Powerheart® G5 AED, Powerheart® AED G3 Plus, and Powerheart® AED G3

Automated External Defibrillators (non-wearable)

FDA Premarket Approval P160033

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the powerheart® aed g3, powerheart® aed g3 plus, and the powerheart® aed g5. The powerheart® aed g3 is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:1) unresponsive;2) not breathing normally; and3) without pulse. When the patient is a child or infant up to 8 years of age, or up to 55 lbs. (25kg), the device should be used with the intellisense defibrillation pad pediatric. The therapy should not be delayed to determine the patient's exact age or weight. The powerheart® aed g3 is intended to be used by personnel who have been trained in its operation. The powerheart® aed g3 plus is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:1) unresponsive;2) not breathing normally; and3) without pulse. When the patient is a child or infant up to 8 years of age, or up to 55 lbs. (25kg), the device should be used with the intellisense defibrillation pad pediatric. The therapy should not be delayed to determine the patient's exact age or weight. The powerheart® aed g3 plus is intended to be used by personnel who have been trained in its operation. The powerheart® aed g5 is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are:1) unresponsive;2) not breathing normally; and3) without pulse. When a patient is a child up to 8 years of age, or up to 25kg (55 lbs. ), the aed should be used with the intellisense defibrillation pad pediatric. The therapy should not be delayed to determine the patient's exact age or weight. The g5 automated external defibrillator (aed) is intended to be used by persons who have been trained in its operation. When used with the optional intellisense defibrillation pad icpr, the device offers cpr performance feedback to aid a trained rescuer by providing compression rate and depth performance feedback through audio prompting. The intellisense defibrillation pad icpr is indicated-for use on cardiac arrest patients 8 years of age or older, or who weigh more than 25 kg (55 lbs. ).

DevicePowerheart® G5 AED, Powerheart® AED G3 Plus, and Powerheart® AED G3
Classification NameAutomated External Defibrillators (non-wearable)
Generic NameAutomated External Defibrillators (non-wearable)
ApplicantCARDIAC SCIENCE CORPORATION
Date Received2016-08-03
Decision Date2018-12-07
PMAP160033
SupplementS
Product CodeMKJ
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address CARDIAC SCIENCE CORPORATION n7 W22025 Johnson Dr suite 100 waukesha, WI 53186

Supplemental Filings

Supplement NumberDateSupplement Type
P160033Original Filing
S008 2021-06-04 30-day Notice
S007
S006
S005 2021-01-08 30-day Notice
S004 2019-08-01 30-day Notice
S003
S002 2019-04-29 Normal 180 Day Track
S001 2018-12-17 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00812394021505 P160033 000
00812394023295 P160033 000
00812394023288 P160033 000
00812394023271 P160033 000
00812394023219 P160033 000
00812394023202 P160033 000
00812394023189 P160033 000
00812394023172 P160033 000
00812394023301 P160033 000
00847946046200 P160033 000
00847946046194 P160033 000
00847946046187 P160033 000
00812394023318 P160033 000
00812394023325 P160033 000
00812394023332 P160033 000
00812394023349 P160033 000
00812394023158 P160033 004
00812394023141 P160033 004
00812394023134 P160033 004
00812394023127 P160033 004
00812394023110 P160033 004
00812394023103 P160033 004
00812394023097 P160033 004
00812394022779 P160033 004
00812394022243 P160033 004
00812394023165 P160033 004

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.